Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rena M Conti

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Pediatrics|January 26, 2025
Prescription Stimulant Dispensing to US Children: 2017-2023Sijia He, Sean Esteban McCabe, Rena M Conti, et al.
Archives of Internal Medicine|January 13, 2010
Impact of FDA black box advisory on antipsychotic medication useE Ray Dorsey, Atonu Rabbani, Sarah A Gallagher, et al.
Pharmacoeconomics|June 14, 2020
Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the USWilliam V Padula, Sonal Parasrampuria, Mariana P Socal, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 7, 2019
Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017Alice J Chen, Xiaohan Hu, Rena M Conti, et al.
Research in Social & Administrative Pharmacy : RSAP|November 22, 2020
60 Years after Kefauver: Household income required to buy prescription drugs in the United States and abroadT Joseph Mattingly, Dominique Seo, Adam M Ostrovsky, et al.
Pharmacoeconomics|November 9, 2020
Reply to Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US"William V Padula, Sonal Parasrampuria, Mariana P Socal, et al.
Pediatrics|December 13, 2016
Use of Low-Value Pediatric Services Among the Commercially InsuredKao-Ping Chua, Aaron L Schwartz, Anna Volerman, et al.
Pediatrics|January 9, 2020
Differences in the Receipt of Low-Value Services Between Publicly and Privately Insured ChildrenKao-Ping Chua, Aaron L Schwartz, Anna Volerman, et al.
The Milbank Quarterly|January 18, 2025
Innovative Insurance to Improve US Patient Access to Cell and Gene TherapyRena M Conti, Patrick Demartino, Jonathan Gruber, et al.
Gene Therapy|November 7, 2023
The estimated annual financial impact of gene therapy in the United StatesChi Heem Wong, Dexin Li, Nina Wang, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Pediatrics|January 26, 2025
Prescription Stimulant Dispensing to US Children: 2017-2023Sijia He, Sean Esteban McCabe, Rena M Conti, et al.
Archives of Internal Medicine|January 13, 2010
Impact of FDA black box advisory on antipsychotic medication useE Ray Dorsey, Atonu Rabbani, Sarah A Gallagher, et al.
Pharmacoeconomics|June 14, 2020
Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the USWilliam V Padula, Sonal Parasrampuria, Mariana P Socal, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 7, 2019
Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017Alice J Chen, Xiaohan Hu, Rena M Conti, et al.
Research in Social & Administrative Pharmacy : RSAP|November 22, 2020
60 Years after Kefauver: Household income required to buy prescription drugs in the United States and abroadT Joseph Mattingly, Dominique Seo, Adam M Ostrovsky, et al.
Pharmacoeconomics|November 9, 2020
Reply to Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US"William V Padula, Sonal Parasrampuria, Mariana P Socal, et al.
Pediatrics|December 13, 2016
Use of Low-Value Pediatric Services Among the Commercially InsuredKao-Ping Chua, Aaron L Schwartz, Anna Volerman, et al.
Pediatrics|January 9, 2020
Differences in the Receipt of Low-Value Services Between Publicly and Privately Insured ChildrenKao-Ping Chua, Aaron L Schwartz, Anna Volerman, et al.
The Milbank Quarterly|January 18, 2025
Innovative Insurance to Improve US Patient Access to Cell and Gene TherapyRena M Conti, Patrick Demartino, Jonathan Gruber, et al.
Gene Therapy|November 7, 2023
The estimated annual financial impact of gene therapy in the United StatesChi Heem Wong, Dexin Li, Nina Wang, et al.
Pageof 14